|Articles|September 1, 2016
- Pharmaceutical Executive-09-01-2016
- Volume 36
- Issue 9
Pharmaceutical Executive, September 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Pharm Exec's Emerging Pharma Leaders 2016about 9 years ago
Emerging Leaders 2016: Lessons from the Front Benchabout 9 years ago
Patient-Centered Strategies for Clinical Trials & Treatmentabout 9 years ago
Rise of the Vox Populiabout 9 years ago
Opioid Epidemic Prompts More Finger Pointing at Pharmaabout 9 years ago
Country Report: France, Part IINewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
